Table 3 Frequency of systemic antifungal strategies used, according to the pre-engraftment profile (N = 95)
Pre-engraftment low risk (n = 29) | Pre-engraftment high riska (n = 54) | GVHDb (n = 12) | Total (N = 95) | |
|---|---|---|---|---|
Not treated with systemic antifungals | 4 (14) | 4 (7) | 2 (17) | 10 (11) |
Treated with systemic antifungals | 25 (86) | 50 (94) | 10 (83) | 85 (89) |
Prophylaxisc | 22 (88) | 39 (78) | 7 (70) | 68 (80) |
Empiric strategyc | 3 (12) | 7 (14) | 1 (10) | 11 (13) |
Pre-emptive or curative strategyc | 0 | 4 (8) | 2 (20) | 6 (7) |